Population
Human cardiovascular tissue array and H9c2 cardiomyoblast cell cultures
Design
Preclinical
Authors
Loading...
May support IGF2R inhibition to limit hypertrophy; leaves open in vivo efficacy and clinical translation.
IGF-II/IGF2R signaling induces cardiac hypertrophy and upregulates ANP/BNP via Gαq interaction and PKC-α/CaMKII activation, suggesting IGF2R suppression as a potential therapeutic strategy for pathological hypertrophy.
Chu et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: